Bangalore, India , November 26, 2024 : Prodancy Pvt. Ltd., a pioneering Medtech startup
specializing in surgical consumables for joint replacement surgeries, has
successfully raised ₹2.14 Crore in a funding round Co-Led by Campus Angels Network and Keiretsu Forum Chennai, It also saw participation from
existing investors Center for Cellular & Molecular Platforms (C-CAMP), and other angel investors which
reaffirmed its confidence in Prodancy through follow-on funding.
This investment will fuel Prodancy’s
growth in India while advancing its plans to expand into global markets,
including the United States. With joint replacement surgeries in India growing
at an impressive 22% CAGR, Prodancy is poised to capitalize on this momentum
through its innovative product portfolio.
Co-founded by Pradeep
Vamana and Venkatesh Parthasarathy, Prodancy is redefining surgical
consumables with a focus on affordability and innovation. Its flagship product,
Vizbl, is the world’s lightest surgical helmet— 40% lighter and 50% more
cost-effective than competitors. The helmet’s unique no-chin-bar design ensures
superior comfort and protection for surgeons during lengthy joint replacement
procedures, addressing critical ergonomic and safety challenges.
Since its launch in early 2023, the
Vizbl helmet has made remarkable progress, with over 230 units sold and 12,000+
surgeries performed using the technology across India’s top hospitals. Prodancy
is now scaling its operations and preparing to meet international regulatory
requirements for its planned entry into global markets.
Leadership Perspectives
Pradeep Vamana, Co-Founder of
Prodancy, shared, “This investment marks a significant milestone in our mission
to deliver made-in-India medical devices for respiratory protection and joint
replacement surgical consumables—a market valued at $4.8 billion. These funds
will expedite our product development and regulatory efforts, including FDA
510(k) approvals, helping us reach more healthcare providers with innovative
solutions that prioritize safety and affordability.”
Venkatesh Parthasarathy, Co-Founder of
Prodancy, added, “At Prodancy, we’re committed to addressing healthcare
challenges through innovation and cost efficiency. By reducing dependency on
imported medical devices, we aim to contribute meaningfully to India’s
healthcare ecosystem. The Vizbl Surgical Helmet was designed to meet surgeons’
specific needs, and this funding brings us closer to delivering broader
impact.”
Chandran Krishnan, Managing Director & CEO of
Campus Angels Network, commented, “Prodancy embodies the kind of transformative
medtech innovation that aligns with our mission. We’re excited to back their
growth as they continue to redefine the respiratory protection and surgical
consumables market. Their founders’ 24 years of combined experience, financial
discipline, and strategic vision make us confident in their success.”
Nitya Raman, Sr. Program Manager at C-CAMP,
noted, “Prodancy’s Vizbl Helmet has demonstrated strong product-market fit by
addressing critical needs for joint replacement surgeons. We are thrilled to
double down on our investment, supporting their leadership and vision in
reducing India’s reliance on imported medical devices.”
Gowtham Sarvesh,
Chief Operating Officer of Keiretsu Forum Chennai & Singapore,
remarked, "Prodancy exemplifies resilience and ingenuity in Medtech.
Building outside conventional incubators, they have achieved EBITDA-positive
growth with a smart distribution model and impactful innovations. We’re proud
to support their expansion and focus on affordability.”
About Prodancy Pvt. Ltd.
Founded by Pradeep Vamana and
Venkatesh Parthasarathy, Prodancy is a Medtech startup revolutionizing surgical
consumables for joint replacement surgeries. With a clear product roadmap for
global expansion and a mission to reduce medical device imports, Prodancy is
set to become a leader in the Medtech space. See more details at www.vizbl.in
For media inquiries:
Pradeep Vamana
pradeep@prodancy.com